Hybrid and surgical procedures for the treatment of persistent and longstanding persistent atrial fibrillation

References

• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:e199–267.
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375.
   PubMed Web of Science ®Google Scholar
• Andrade J, Khairy P, Drobomir D, et al. The clinical profile and pathophysiology of atrial fibrillation. relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114:1453–1468.
   PubMed Web of Science ®Google Scholar
• Goette A, Kalman JM, Aguinaga L, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace. 2016;18(10):1455–1490.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271:840–844.
   PubMed Web of Science ®Google Scholar
• Santangeli P, Di Biase L, Bai R, et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm. 2012;9:1761–1768.
   PubMed Web of Science ®Google Scholar
• Kalantarian S, Stern TA, Mansour M, et al. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med. 2013;158:338–346.
   PubMed Web of Science ®Google Scholar
• Bansal N, Fan D, Hsu CY, et al. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013;127:569–574.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174:107–114.
   PubMed Web of Science ®Google Scholar
• Dukes JW, Marcus GM. Atrial fibrillation begets myocardial infarction. JAMA Intern Med. 2014;174:5–7.
   PubMed Web of Science ®Google Scholar
• Haissaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England J Med. 1998;339(10):659–666.
   PubMed Web of Science ®Google Scholar
• Brooks AG, Stiles MK, Laborderie J, et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm. 2010;7(6):835–846.
   PubMed Web of Science ®Google Scholar
• Tilz RR, Rillig A, Thum AM, et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol. 2012;60:1921–1929.
   PubMed Web of Science ®Google Scholar
• Caulkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):October.
   Web of Science ®Google Scholar
• Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015 7;372(19):1812–1822.
   PubMed Web of Science ®Google Scholar
• Vogler J, Willems S, Sultan A, et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol. 2015;66(24):2743–2752.
   PubMed Web of Science ®Google Scholar
• Szilágyi J, Marcus GM, Badhwar N, et al. Atrial fibrillation patients with isolated pulmonary veins: is sinus rhythm achievable? J Cardiovasc Electrophysiol. 2017 Jul;28(7):754–761.
   PubMed Web of Science ®Google Scholar
• Sawhney, N., Anousheh R, Chen W, et al. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(3):243–248.
   PubMed Web of Science ®Google Scholar
• Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg. 1991;101:584–592.
   PubMed Web of Science ®Google Scholar
• Cox JL, Boineau JP, Schuessler RB, et al. Successful surgical treatment of atrial fibrillation. JAMA. 1991;266:1976–1980.
   PubMed Web of Science ®Google Scholar
• Damiano RJ Jr., Gaynor SL, Bailey M, et al. The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. J Thorac Cardiovasc Surg. 2003;126:2016–2021.
   PubMed Web of Science ®Google Scholar
• Lawrance CP, Henn MC, Miller JR, et al. A minimally invasive Cox maze IV procedure is as effective as sternotomy while decreasing major morbidity and hospital stay. J Thorac Cardiovasc Surg. 2014;148:955–961.
   PubMed Web of Science ®Google Scholar
• Damiano RJ Jr. Alternative energy sources for atrial ablation: judging the new technology. Ann Thorac Surg. 2003;75:329–330.
   PubMed Web of Science ®Google Scholar
• Pak HN, Hwang C, Lim HE, et al. Hybrid epicardial and endocardial ablation of persistent or permanent atrial fibrillation: a new approach for difficult cases. J Cardiovasc Electrophysiol. 2007;2007(18):917–923.
   Google Scholar
• Beyer E, Lee R, Lam BK. Point: minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: early multicenter results. J Thorac Cardiovasc Surg. 2009;137:521–526.
   PubMed Web of Science ®Google Scholar
• Holmes DR, Reddy VY, Turi ZG, et al. for the PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–542.
   PubMed Web of Science ®Google Scholar
• Boersma LV, Castella M, van Boven W, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125:23–30.
   PubMed Web of Science ®Google Scholar
• Kiser AC, Landers MD, Boyce K, et al. Simultaneous catheter and epicardial ablations enable a comprehensive atrial fibrillation procedure. Innovations (Phila). 2011;6:243–247.
   PubMedGoogle Scholar
• Gehi AK, Mounsey JP, Pursell I, et al. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10:22–28.
   PubMed Web of Science ®Google Scholar
• Geršak B, Zembala MO, Müller D, et al. European experience of the convergent atrial fibrillation procedure: multicenter outcomes in consecutive patients. J Thorac Cardiovasc Surg. 2014;147(4):1411–1416.
   PubMed Web of Science ®Google Scholar
• Badhwar N, Tschopp DR, Lee RJ. Surgical and concomitant epicardial-endocardial (hybrid) ablation of persistent and long-standing persistent atrial fibrillation. Curr Probl Cardiol. 2015;40(6):245–267.
   PubMed Web of Science ®Google Scholar
• Bartus K, Han FT, Bednarek J, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62(2):108–118.
   PubMed Web of Science ®Google Scholar
• Bulava A, Mokracek A, Hanis J, et al. Correlates of arrhythmia recurrence after hybrid epi- and Endocardial radiofrequency ablation for persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2017 Aug;10(8):pii: e005273.
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014 8;64(1):1–12.
   PubMed Web of Science ®Google Scholar
• Sievert H, Rasekh A, Bartus K, et al. Left atrial appendage ligation in nonvalvular atrial fibrillation patients at high risk for embolic events with inel- igibility for oral anticoagulation: initial report of clinical outcomes. J Am Coll Cardiol EP. 2015;1:465–474.
   Google Scholar
• Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention. 2016;11(10):1170–1179.
   PubMed Web of Science ®Google Scholar
• Reddy VY, Akehurst RL, Armstrong SO, et al. Time to cost-effectiveness following stroke reduction strategies in AF: warfarin versus NOACs versus LAA closure. J Am Coll Cardiol. 2015;66(24):2728–2739.
   PubMed Web of Science ®Google Scholar
• Panikker S, Lord J, Jarman JW, et al. Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation. Eur Heart J. 2016.
   PubMedGoogle Scholar
• Holmes DR Jr, Doshi SK, Kar S, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015;65(24):2614–2623.
   PubMed Web of Science ®Google Scholar
• Phillips KP, Walker DT, Humphries JA. Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: five-year experience. J Arrhythm. 2016;32(2):119–126.
   PubMed Web of Science ®Google Scholar
• Swaans MJ, Post MC, Rensing BJ, et al. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012;1(5):e002212.
   PubMed Web of Science ®Google Scholar
• Heeger CH, Rillig A, Lin T, et al. Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices. Heart Rhythm. 2015;12(7):1524–1531.
   PubMed Web of Science ®Google Scholar
• Panikker S, Jarman JW, Virmani R, et al. Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol. 2016;9(7):pii: e003710.
   Web of Science ®Google Scholar
• Turagam MK, Lavu M, Afzal MR, et al. Catheter ablation for atrial fibrillation in patients with watchman left Atrial appendage occlusion device: results from a multicenter registry. J Cardiovasc Electrophysiol. 2017;28(2):139–146.
   PubMed Web of Science ®Google Scholar
• Gabriels J, Beldner S, Khan M, et al. Embolization of watchman device following a hybrid radiofrequency ablation of atrial fibrillation and watchman implantation procedure. J Cardiovasc Electrophysiol. 2017 Jul;28(7):835–836.
   PubMed Web of Science ®Google Scholar
• Badhwar N, Lakkireddy D, Kawamura M, et al. Sequential percutaneous LAA ligation and pulmonary vein isolation in patients with persistent AF: initial results of a feasibility study. J Cardiovasc Electrophysiol. 2015;26:608–614.
   PubMed Web of Science ®Google Scholar
• Lakkireddy D, Mahankali AS, Kanmanthareddy A, et al. Left Atrial Appendage Ligation and Ablation for Persistent Atrial Fibrillation (LAALA-AF Registry). J Am Coll Cardiol EP. 2015;1:153–160.
   Google Scholar
• Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109–118.
   PubMed Web of Science ®Google Scholar
• Rillig A, Tilz RR, Lin T, et al. Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2016;9(5):e003461.
   PubMed Web of Science ®Google Scholar
• Han FT, Bartus K, Lakkireddy DJ, et al. The effects of LAA ligation on LAA electrical activity. Heart Rhythm. 2014;11:864–870.
   PubMed Web of Science ®Google Scholar
• Afzal MR, Kanmanthareddy A, Earnest M, et al. Impact of Left Atrial appendage exclusion using an Epicardial Ligation System (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Heart Rhythm. 2015;12:52–59.
   PubMed Web of Science ®Google Scholar
• Bartus K, Morelli RL, Szczepanski W, et al. Anatomic analysis of the left atrial appendage after closure with the LARIAT device. Circ Arrhythm Electrophysiol. 2014 Aug;7(4):764–767.
   PubMed Web of Science ®Google Scholar
• Badhwar N, Mittal S, Rasekh A, et al. Conversion of persistent atrial fibrillation to sinus rhythm after LAA ligation with the LARIAT device. Int J Cardiol. 2016 Dec;15(225):120–122.
   Google Scholar
• Lee RJ, Lakkireddy D, Mittal S, et al. Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): rationale and design. Am Heart J. 2015;170(6):1184–1194.
   PubMed Web of Science ®Google Scholar